KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Cash & Current Investments (2016 - 2025)

CareDx (CDNA) has disclosed Cash & Current Investments for 13 consecutive years, with $177.2 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments fell 32.01% to $177.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $177.2 million through Dec 2025, down 32.01% year-over-year, with the annual reading at $177.2 million for FY2025, 32.01% down from the prior year.
  • Cash & Current Investments hit $177.2 million in Q4 2025 for CareDx, down from $194.2 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $374.3 million in Q1 2021 to a low of $177.2 million in Q4 2025.
  • Historically, Cash & Current Investments has averaged $273.6 million across 5 years, with a median of $275.4 million in 2023.
  • Biggest five-year swings in Cash & Current Investments: skyrocketed 1062.71% in 2021 and later plummeted 32.01% in 2025.
  • Year by year, Cash & Current Investments stood at $348.5 million in 2021, then dropped by 15.9% to $293.1 million in 2022, then fell by 19.68% to $235.4 million in 2023, then grew by 10.72% to $260.7 million in 2024, then plummeted by 32.01% to $177.2 million in 2025.
  • Business Quant data shows Cash & Current Investments for CDNA at $177.2 million in Q4 2025, $194.2 million in Q3 2025, and $186.3 million in Q2 2025.